每(mei)經(jing)AI快訊，華北制藥(yao)（SH 600812，收盤價：5.7元(yuan)）10月12日(ri)晚(wan)間發布公(gong)(gong)(gong)(gong)(gong)(gong)告稱，截至本公(gong)(gong)(gong)(gong)(gong)(gong)告披露日(ri)，公(gong)(gong)(gong)(gong)(gong)(gong)司(si)及控股(gu)(gu)子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)對(dui)外擔保(bao)(bao)總(zong)額(e)約(yue)為(wei)27.53億元(yuan)，占(zhan)2021年(nian)度(du)經(jing)審(shen)(shen)計歸屬(shu)于(yu)上(shang)市(shi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)普通(tong)股(gu)(gu)股(gu)(gu)東凈(jing)資(zi)(zi)產的(de)45.24%，其中公(gong)(gong)(gong)(gong)(gong)(gong)司(si)為(wei)控股(gu)(gu)子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)提供(gong)擔保(bao)(bao)總(zong)額(e)約(yue)為(wei)25.63億元(yuan)，占(zhan)2021年(nian)度(du)經(jing)審(shen)(shen)計歸屬(shu)于(yu)上(shang)市(shi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)普通(tong)股(gu)(gu)股(gu)(gu)東凈(jing)資(zi)(zi)產的(de)42.12%；控股(gu)(gu)子(zi)(zi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)為(wei)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)提供(gong)擔保(bao)(bao)總(zong)額(e)為(wei)1億元(yuan)，占(zhan)2021年(nian)度(du)經(jing)審(shen)(shen)計歸屬(shu)于(yu)上(shang)市(shi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)普通(tong)股(gu)(gu)股(gu)(gu)東凈(jing)資(zi)(zi)產的(de)1.64%；對(dui)合(he)并報表外單位擔保(bao)(bao)金額(e)為(wei)9000萬元(yuan)，占(zhan)2021年(nian)度(du)經(jing)審(shen)(shen)計歸屬(shu)于(yu)上(shang)市(shi)公(gong)(gong)(gong)(gong)(gong)(gong)司(si)普通(tong)股(gu)(gu)股(gu)(gu)東凈(jing)資(zi)(zi)產的(de)1.48%。

2021年(nian)1至12月份(fen)，華(hua)北(bei)制藥(yao)(yao)的營業(ye)收入構成為：化學制劑藥(yao)(yao)占比(bi)(bi)47.54%，化學原料藥(yao)(yao)占比(bi)(bi)20.96%，生(sheng)物制劑占比(bi)(bi)14.66%，醫(yi)藥(yao)(yao)及(ji)其它物流貿易(yi)占比(bi)(bi)8.65%，醫(yi)藥(yao)(yao)中間體占比(bi)(bi)4.54%。

華北制藥的(de)董事長(chang)是張玉祥，男，58歲，學歷(li)背(bei)景為碩(shuo)士；總經理是劉新彥(yan)，男，52歲，學歷(li)背(bei)景為碩(shuo)士。

截至(zhi)發稿，華(hua)北制藥(yao)市值為98億元。

道達號（daoda1997）“個股(gu)趨勢”提醒：
1. 近30日內無機構對華北制藥進行調研。
更(geng)多個股趨勢信(xin)息，請搜索微信(xin)公眾號“道達(da)號”，回(hui)復“查詢(xun)”，領取免費(fei)查詢(xun)權限！

每(mei)經頭條（nbdtoutiao）——

(記者 王曉波)

免責聲明：本文(wen)內(nei)容與數據僅供參考，不構(gou)成(cheng)投資建議，使(shi)用前(qian)請核實。據此操作(zuo)，風險自(zi)擔。